Phase 2 study of AKCEA-APOCIII-LRx in patients with hypertriglyceridaemia and established cardiovascular disease (CVD) (NCT03385239)

Educational partners and supporters (others pending)

Amarin Logo
Ionis Logo
Kowa Logo
Pfizer Logo